MannKind Corp (NASDAQ:MNKD)
| 4.18 Delayed Data As of May 23 |  +0.49 / +13.32%Today’s Change | 2.49 Today|||52-Week Range 5.53 | -4.46% Year-to-Date |
Latest MNKD News | Press Releases
No recent news for MannKind Corp.
Today’s Trading
| Previous close | 3.68 |
| Today’s open | 3.73 |
| Day’s range | 3.57 - 4.77 |
| Volume | 25,427,103 |
| Average volume (3 months) | 3,652,821 |
| Market cap | $929.4M |
Data as of 3:59pm ET, 05/23/2022
Growth & Valuation
| Earnings growth (last year) | -26.24% |
| Earnings growth (this year) | +14.21% |
| Earnings growth (next 5 years) | +30.20% |
| Revenue growth (last year) | +15.81% |
| P/E ratio | NM |
| Price/Sales | 14.44 |
| Price/Book | -- |
Competitors
| ---- | ||
| ENTAEnanta Pharmaceutica... | +0.60 | +1.43% |
| RVNCRevance Therapeutics... | -0.60 | -4.36% |
| KURAKura Oncology Inc | +0.16 | +1.27% |
Data as of 4:00pm ET, 05/23/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $75.4M |
| Annual profit (last year) | -$80.9M |
| Net profit margin | -107.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Danbury, Connecticut |
Forecasts
